Get started
Author

Mariacristina Ciccioli

Observed names: Ciccioli, Mariacristina, M. Ciccioli
ORCID: 0009-0000-2518-0878
Observed ORCID: 0009-0000-2518-0878
OpenAlex ID: A5020823576
Analytical performance of the FDA-cleared Parsortix® PC1 system
2023 · Amy Templeman, M. Craig Miller, et al. · Journal of Circulating Biomarkers · 38
PDF
Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
2024 · Mariacristina Ciccioli, Kyukwang Kim, et al. · Journal of Experimental & Clinical Cancer Research · 24
PDF
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells
2019 · Elizabeth Foxall, Adela Staszowska, et al. · Cell Reports · 23
Plasticity in leukocyte migration during haematopoiesis and inflammation
2025 · C. Villella, M. Ciccioli, et al. · Journal of Muscle Research and Cell Motility · 4
PDF
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells
2020 · Elizabeth Foxall, Adela Staszowska, et al. · Cell Reports · 4
PDF
Abstract 588: Mesenchymal markers: The new avenue for circulating tumor cells detection
2021 · Mariacristina Ciccioli, Natalia Bravo-Santano, et al. · Cancer Research · 3
Abstract 3705: Development and analytical validation of a novel assay for HER2 assessment on circulating tumor cells using Parsortix® isolation and BioView imaging technologies
2024 · Mariacristina Ciccioli, Alex Young, et al. · Cancer Research · 2
Interrogating HER2 status in Circulating Tumor Cells isolated using the Parsortix® System from Metastatic Breast Cancer patients
2024 · A. Young, L. Vlietinck, et al. · European Journal of Cancer · 2
PDF
Abstract A046: Development of a scoring system to classify HER2 protein expression in circulating tumor cells through immunofluorescence following isolation using Parsortix® instruments
2024 · Alex Young, Laila Vlietinck, et al. · Clinical Cancer Research · 1
Abstract P1-05-35: Identification of Circulating Tumor Cells captured by the FDA Cleared Parsortix® PC1 System from the Peripheral Blood of Metastatic Breast Cancer Patients using Immunofluorescence and Cytopathological Evaluations
2023 · Mariacristina Ciccioli, Richard Moore, et al. · Cancer Research · 1
Abstract 599: Investigation of PD-L1 expression in circulating tumor cells isolated using the Parsortix system in metastatic lung and breast cancer patients
2021 · Mariacristina Ciccioli, Amy Davis, et al. · Cancer Research · 1
Biom-71. Unlocking the Potential of Liquid Biopsy in Glioblastoma: an Extensive Evaluation of Circulating Biomarkers
2025 · Mariacristina Ciccioli, Morgan Spode, et al. · Neuro-Oncology
PDF
Abstract 1981: Analytical validation of ANGLE's combined IF and FISH assay for assessment of HER2 in circulating tumor cells
2025 · Mariacristina Ciccioli, Alex Young, et al. · Cancer Research
Abstract A038: Investigating PD-L1 status in circulating tumor cells isolated from blood samples of lung cancer patients
2024 · Morgan Spode, Chloe Goodwin, et al. · Clinical Cancer Research
Integrating isolation using label-independent microfluidics and advanced staining for comprehensive Circulating Tumor Cell Analysis
2024 · M. Ciccioli, D. Greaves, et al. · European Journal of Cancer
PDF
Abstract 1033: Evaluation of HER2 status in circulating tumor cells isolated using the Parsortix® system
2023 · Nerea Borreguero-Munoz, Alex Young, et al. · Cancer Research
Abstract 969: Epithelial and mesenchymal CTC detection in triple negative breast cancer patients using ANGLE’s Parsortix®system
2022 · Amina Mezni, Matthew Hardy, et al. · Cancer Research
Isolation of ovarian cancer circulating tumor cells using an epitope independent microfluidic cell capture device and their interrogation using a multiplex gene expression assay or immunofluorescence
2020 · N. Khazan, K. Kim, et al. · Gynecologic Oncology
Investigation of the role of WIP and WASP in regulating myeloid cells migration during mild hyperthermia
2020 · Mariacristina Ciccioli
Works count: 26
Citation count: 103
H-index: 4
I10-index: 3
Year
Topic
Type